Vasaka and the classical respiratory herbs

Vasaka is the ingredient at the centre of almost every Ayurvedic cough preparation sold in India, and it is usually described in a single vague line.

It deserves better, because the classical reasoning behind it is specific and the modern evidence is genuinely interesting, and because the regulatory and safety facts in this category matter more than the pharmacology does.

We manufacture respiratory products. That is the reason to be careful here, not to be enthusiastic.

This is information, not medical advice. Nothing here treats asthma, COPD or any respiratory disease, and no herb replaces an inhaler.

The classical framework, on its own terms

Worth setting out, because it is more structured than the marketing suggests.

Ayurveda does not treat “cough” as one thing. Kasa (cough) is classically divided into types by the dominant dosha and by presentation, including a dry, scanty, painful cough and a productive, heavy, loose one, and the treatment differs by type.

Shvasa (breathing difficulty) is a separate classification, with tamaka shvasa describing a presentation that corresponds reasonably well to what we would now call asthma, episodic, worse at night, worse in damp or cold.

And the functional categories the herbs fall into:

• Kasahara, relieving cough
• Shvasahara, relieving breathlessness
• Kaphaghna, reducing or thinning phlegm
• Vatanulomana, regulating the downward movement of vata

The reason this structure matters commercially: a classical practitioner would choose differently for a dry cough than for a wet one. A single product sold for “all coughs” is not following the classical framework it borrows its ingredients from, and that is a fair criticism of most of this market, ours included unless we are careful.

And the classical therapeutic approach is broader than herbs: dhuma (medicated smoke inhalation), nasya (nasal instillation), steam, and dietary regulation, avoiding cold, heavy and kapha-increasing foods during an episode.

On dhuma and nasya, our position is plain: inhaling smoke of any kind is not something we would recommend, and oily nasya preparations carry a real aspiration risk that we have written about elsewhere. Traditional practice is not automatically safe practice, and saying so is part of taking the tradition seriously.

Vasaka

Adhatoda vasica, also Malabar nut, adulsa, vasa, arusa. The leaves are the part used.

Why the texts use it

It is classified as kasahara and kaphaghna, and it appears in a large number of classical cough formulations, Vasavaleha, Vasarishta, Vasakasava among them, and it is a component of Sitopaladi and many proprietary cough syrups.

And its best-known classical indication is raktapitta, bleeding disorders, including blood-stained sputum. That is a distinctive and quite specific traditional use, and it is worth noting because it is not the use it is marketed for.

The chemistry

The principal alkaloid is vasicine (also written vasicinone and related compounds).

And here is the detail that makes vasaka genuinely interesting rather than merely traditional:

Vasicine was the starting point for the development of bromhexine and ambroxol, two mucolytic drugs in wide pharmaceutical use today, including in India.

So this is a case where a classical herb led to a real, licensed modern medicine. That is uncommon and it is worth stating accurately: the drugs are semi-synthetic derivatives, not the herb itself, and their evidence belongs to them rather than to vasaka leaf.

But it does mean the traditional classification as a phlegm-thinning agent has a coherent chemical basis, the tradition identified a plant whose alkaloid scaffold turned out to be mucoactive.

What modern studies show

Reported in laboratory and animal work: bronchodilator, expectorant and mucolytic activity, anti-inflammatory and antimicrobial effects, and uterine stimulant (oxytocic) activity, which is the basis of a safety warning below.

Human evidence: limited. Small studies, often of multi-ingredient formulations, generally without good blinding. There is no body of human trial evidence that would support a treatment claim for vasaka leaf itself.

Honest summary: long and consistent traditional use, a genuinely coherent chemical story, derivative drugs in real clinical use, and preliminary human evidence for the herb.

Safety

Pregnancy, avoid. The oxytocic activity reported in animal studies is a real reason for caution, and vasaka appears in traditional lists of herbs to avoid in pregnancy. We do not promote it for pregnancy.

Bleeding risk, theoretical interaction with anticoagulants.

High doses may cause nausea and gastrointestinal upset.

And it is not a treatment for an asthma attack. Bronchodilator activity in a laboratory is not a reliever inhaler.

The rest of the classical respiratory group

Pushkarmool (Inula racemosa)

Classically shvasahara and used for chest complaints, and notably it appears in classical contexts for chest pain and cardiac complaints too.

Preliminary work has looked at bronchodilatory and cardiac effects. Human evidence is thin.

Worth flagging: it is a plant under conservation pressure in the Himalaya. Sourcing matters here, and a manufacturer should be able to say where it came from.

Mulethi / Yashtimadhu (Glycyrrhiza glabra)

Classically soothing to the throat and kasahara. Demulcent, and genuinely effective at easing a sore, raw throat.

And this is the ingredient in the group with the most important safety warning:

Glycyrrhizin causes pseudohyperaldosteronism, sodium retention, potassium loss and raised blood pressure, with sustained regular use. Reported consequences include hypertension, hypokalaemia, muscle weakness and cardiac arrhythmia.

So: not for long-term daily use, particularly in hypertension, heart disease, kidney disease, or anyone on diuretics or digoxin. Deglycyrrhizinated liquorice (DGL) avoids most of this and loses some of the effect.

We require this warning on artwork containing meaningful mulethi, and most of this market does not print it.

Tulsi (Ocimum sanctum)

Long traditional use for cough, cold and fever, and small human studies. Caution with anticoagulants.

Kantakari (Solanum xanthocarpum) and Bharangi

Classical kasahara and shvasahara ingredients, appearing in Dashamoola and in the classical ten-root group.

Vanshlochan (bamboo manna)

Classically cooling and used for dry cough, in Sitopaladi.

Pippali (long pepper) and Trikatu

Classically kaphaghna and used as a yogavahi, a bioavailability enhancer. Piperine’s effect on the absorption of other compounds is real and documented, which is why it recurs in formulations.

And a consequence that is under-appreciated: an absorption enhancer can raise the blood levels of prescription drugs taken at the same time. This is a genuine interaction risk, not a feature to be marketed uncritically.

Nirgundi (Vitex negundo)

Classical use in respiratory and inflammatory complaints, and in classical smoke inhalation preparations, which, again, we would not recommend.

Haridra (turmeric), Guduchi (giloy), Shunthi (ginger), Talisapatra, Shirish

All appear in this space.

And a specific safety note on giloy, since it is ubiquitous: cases of liver injury associated with prolonged or high-dose use have been reported. Not for indefinite daily use, and caution with pre-existing liver disease.

Ginger has the best modern evidence of the group for nausea, and reasonable traditional grounding here.

The classical formulations

Sitopaladi churna, Vasavaleha, Talisadi churna, Dashamoolarishta, Kanakasava, Chyawanprash, Agastya Haritaki, Sitopaladi, and Trikatu.

And a practical fact about arishta and asava preparations that is rarely mentioned: they contain self-generated alcohol and significant sugar.

This matters if: the product is for a child, for a person with diabetes, in pregnancy or lactation, for someone avoiding alcohol, or for anyone on a medicine that interacts with alcohol (metronidazole, for instance). Kanakasava is widely given for cough and this is almost never discussed.

Honey, which deserves its own line

Honey has the best evidence of anything in this article for cough.

Trials in children have found honey comparable to or better than common over-the-counter cough preparations for nocturnal cough and sleep quality, and it is recommended in some clinical guidance for cough in children over one.

It is cheap, it is traditional, and it works.

And the warning that must accompany it: never give honey to an infant under one year. Risk of infant botulism. This is absolute.

What this category can honestly be

A soothing preparation for an irritated throat and an unproductive cough, built on ingredients with long traditional use, with honest safety warnings and clean test reports.

That is a real, useful, sellable product.

What it cannot be: a treatment for asthma, COPD, pneumonia or tuberculosis; a substitute for an inhaler; or a protection against air pollution.

And the specific harm to name: delay. In this category the serious diagnoses, tuberculosis, asthma, COPD, lung cancer, heart failure, all present as cough or breathlessness, and a syrup that makes a person feel managed for six weeks is how those diagnoses get missed.

In India, with the tuberculosis burden we have, a cough syrup that does not say “if this lasts more than three weeks, get tested” is a product with a gap in it. We print that line.

The quality questions a buyer should ask

More important than any of the pharmacology above.

Batch-wise heavy metals, lead, mercury, arsenic, cadmium. Herbal products in this market have repeatedly been found contaminated, and leafy raw materials are a common route.

Microbiology, and pesticide residues on the botanicals.

Identity and marker-compound assay, is the vasicine content specified, or is it just “vasaka extract”?

Adulteration screening. Undeclared pharmaceuticals in cough preparations are a documented problem, antihistamines, dextromethorphan, and in the worst cases codeine. A syrup that sedates a child markedly is a reason for alarm, not satisfaction.

And a serious one specific to syrups: diethylene glycol and ethylene glycol contamination of the solvent base. This has caused child deaths linked to Indian-made cough syrups, and the testing, of every batch of glycerin and propylene glycol, for DEG and EG, is not optional. Any manufacturer of a liquid preparation should be able to produce those certificates immediately.

Licence number on the pack, and verify it.

We would rather be judged on whether we can produce those documents than on our ingredient story.

Licensing, and why label wording differs

Two routes, and the difference is not cosmetic.

A classical Ayurvedic medicine, made to a formulation in a text recognised in the First Schedule of the Drugs and Cosmetics Act, licensed by the state AYUSH authority, may carry the indications the text gives. That is why a licensed Vasavaleha can say things a supplement cannot.

A food supplement / nutraceutical under FSSAI may make no medicinal claims at all, only authorised nutrient-function claims and traditional-use statements.

And over both sits the Drugs and Magic Remedies (Objectionable Advertisements) Act, which restricts advertising for a schedule of conditions whatever licence you hold.

The commonest compliance failure in this category is exactly this: a company lifts the indications from a classical text and prints them on a food-supplement label. That is not a grey area.

Claims, what we print and what we refuse

What is sayable on a food supplement: traditional-use statements, that vasaka, tulsi, mulethi and pushkarmool have long traditional use in Ayurveda for cough and respiratory complaints, framed clearly as traditional use, plus authorised nutrient-function claims for any vitamins and minerals present (vitamin C, vitamin D and zinc contributing to the normal function of the immune system).

What is not sayable: treats asthma, relieves breathlessness, cures cough, clears the lungs, increases lung capacity, or protects from pollution.

What we refuse outright: “lung detox” and “pollution shield” positioning; any claim referencing tuberculosis; and paediatric syrups formulated to sedate.

And what we require on artwork: the three-week cough warning, the mulethi blood-pressure caution where relevant, the “not for infants under one year” line on anything containing honey, and the sugar and alcohol declaration on asava-type preparations.

When to see a doctor

Urgently:

• Breathlessness at rest, or unable to finish a sentence
• Blue lips or fingertips
• Chest pain
• An asthma attack not responding to the reliever
• In a child: fast breathing, chest indrawing, grunting, or not feeding

Soon:

• A cough lasting more than three weeks, tuberculosis testing
• Coughing up blood
• Unintentional weight loss, or night sweats
• Breathlessness that is new or worsening
• Night-time cough or wheeze, poorly controlled asthma
• Before taking vasaka in pregnancy, avoid
• Before taking mulethi with hypertension, heart disease, kidney disease, diuretics or digoxin
• Before giving any Ayurvedic preparation to a child, particularly an asava or a bhasma

The short version

1. Ayurveda classifies cough into types and treats them differently, a product for “all coughs” is not following that framework.
2. Tamaka shvasa corresponds reasonably to asthma in the classical texts.
3. Vasaka is classically kasahara and kaphaghna, and its best-known classical use is bleeding disorders.
4. Its alkaloid vasicine led to bromhexine and ambroxol, real mucolytic drugs. The drugs’ evidence is not the herb’s.
5. Human evidence for vasaka leaf itself is preliminary.
6. Avoid vasaka in pregnancy, reported oxytocic activity.
7. Mulethi raises blood pressure and lowers potassium with sustained use. Not for daily long-term use.
8. Pushkarmool is under conservation pressure, ask about sourcing.
9. Piperine enhances absorption, which can raise levels of prescription drugs taken alongside.
10. Giloy has reported liver injury cases with prolonged or high-dose use.
11. Honey has the best cough evidence of anything here, and never under one year.
12. Asava and arishta contain alcohol and sugar, relevant for children, diabetes and pregnancy.
13. Smoke inhalation and oily nasal instillation we do not recommend, aspiration risk is real.
14. Ask for batch-wise heavy metals, pesticides and microbiology.
15. Ask whether the marker compound is assayed, or whether it is just “extract”.
16. Undeclared sedating pharmaceuticals in cough syrups are a documented problem.
17. DEG and EG testing of every solvent batch is not optional, children have died.
18. Classical medicines and food supplements are licensed differently, and a supplement cannot borrow a text’s indications.
19. The Drugs and Magic Remedies Act applies regardless of licence.
20. Delay is the real harm, TB, asthma, COPD, cancer and heart failure all present as cough.
21. Three weeks of cough means a TB test. Print it on the pack.

Composition detail: Oxivo 360 and tulsi capsule. Related: खाँसी का घरेलू इलाज, air pollution, what actually helps, and licences for Ayurvedic manufacturing.